Dr. Reshma Kewalramani
Company: Vertex PharmaceuticalsTitle: President & CEOIndustry: PharmaceuticalsNotable in 2024: Dr. Kewalramani won regulatory approval for its...
Read More
US drug regulator approves new non-addictive pain pill
The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain medicines.
Read MoreEnd of content
No more pages to load